WIESLAB® Complement System Classical Pathway - RUO

COMPLCP310RUO

RUO ELISA enabling sensitive detection of classical pathway activation to support exploratory research into autoimmune and inflammatory disease models.

  • Reliable, objective, and easy-to-interpret results
  • Results in just a few hours
  • Low inter-assay variability and excellent reproducibility
  • Developed by our in-house experts in collaboration with key opinion leaders
  • Ready-to-use reagents for a streamlined workflow
  • Excellent specificity means clear results without false positives
Add to quote
WIESLAB®  Complement System Classical Pathway - RUO

Product Overview

The Wieslab® Complement System Classical Pathway is an enzyme immunoassay for the qualitative and/or semi-quantitative determination of functional classical complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab® Complement System Classical Pathway.

The Wieslab Complement System Classical Pathway assay combines the specific activation of the pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as the result of complement activation. The amount of complement activation can be expressed either in a qualitative way relative the value of a positive control or in a semi-quantitative way using a calibrator curve derived from a separate lyophilized activity control. 

The Wieslab Complement assays have been reported in literature as useful tools in the evaluation of complement therapeutics, in clinic, clinical trials and in drug development.

FOR RESEARCH USE ONLY

This product is also available for in vitro diagnostic use - Product code: COMPL CP310

What's in the box?

  • One frame with break-apart wells (12x8)
  • 2 x 35 mL Diluent CP
  • 13 mL Conjugate
  • 13 mL Substrate solution
  • 30 mL Wash solution 30x concentrated
  • 0,2 mL Negative control (NC) containing human serum
  • Lyophilized positive control (PC) containing human serum
  • Lyophilized activity control (AC) for semi-quantitative application, containing human serum

Please note: All reagents in the kit are ready to use except wash solution and controls. The reagents should be stored at 2-8° C. The positive control and the activity control should be stored at -20° C upon arrival. The reconstituted positive control and activity control should be stored at –70° C and may be thawed once.

Specifications

Product code COMPLCP310RUO
Size 96 wells
Technology ELISA
Detection system ALP/pNPP read at 405 nm
Regulatory status Research Use Only
Assay time 2h

Downloads

previous
Complement System Specialist Review

Complement System Specialist Review

Read post
Unraveling Complement’s Role in Blindness: The Work of Professor Simon Clark

Unraveling Complement’s Role in Blindness: The Work of Professor Simon Clark

Read post
Insights on Targeting Complement Dysregulation - Dr. Elena Goicoechea de Jorge

Insights on Targeting Complement Dysregulation - Dr. Elena Goicoechea de Jorge

Read post
20 Years of Innovation: The Legacy of the WIESLAB® Complement System Assays

20 Years of Innovation: The Legacy of the WIESLAB® Complement System Assays

Read post
Meet the 2025 Svar Complement Excellence Award Recipients

Meet the 2025 Svar Complement Excellence Award Recipients

Read post
Insights from Two Complement Excellence Award Recipients

Insights from Two Complement Excellence Award Recipients

Read post
The Importance of Investigating Complement System in Gene Therapy

The Importance of Investigating Complement System in Gene Therapy

Read post
Get a Free Complement System Poster

Get a Free Complement System Poster

Read post
Roundtable: Challenges & Solutions in Next-Gen Complement Therapeutics

Roundtable: Challenges & Solutions in Next-Gen Complement Therapeutics

Read post
Exploring Existing Human Complement C4d, TCC & Functional Activity Assays

Exploring Existing Human Complement C4d, TCC & Functional Activity Assays

Read post
A Guide to Complement Therapeutics for Drug Development Professionals

A Guide to Complement Therapeutics for Drug Development Professionals

Read post
next